drug · small molecule
patient view →(dexborneol + edaravone)
Phase 3updated 2mo agoby Simcere Pharmaceutical Group Ltd🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for axial length measurement and amyotrophic lateral sclerosis and 6 investigational indications.
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that